Tumour cell density quantified by artificial intelligence is associated with differential benefit from irinotecan-based chemo-radiotherapy in locally advanced rectal cancer: a post-hoc study of the phase 3 ARISTOTLE trial.

Shen Z et al.

NCBI PubMed Central · Papers · License: Open Access

machine learning systems

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 458661
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.